Dr. Gary Novack Attends Glaucoma Research Society Meeting in Cambridge

Dr. Gary Novack recently attended the biennial meeting of the Glaucoma Research Society in Cambridge, United Kingdom.

The Glaucoma Research Society is a public-interest, nonprofit scientific association of leading glaucoma researchers that provides a forum to discuss and stimulate compelling and innovative research aimed at preventing glaucoma-related disability worldwide. Membership is limited to 100 researchers.

During the meeting, Dr. Novack had the opportunity to hear a wide range of novel research presentations and contribute his perspective on the development of new therapies for glaucoma.

Learn more about the Glaucoma Research Society.

About Dr. Novack

Dr. Gary Novack is a board-certified clinical pharmacologist and President of PharmaLogic Development with more than 40 years of experience in ophthalmic drug development, clinical research, and FDA regulatory strategy.

He has consulted for over 100 pharmaceutical and medical device companies and authored more than 400 scientific publications.

Contact Dr. Novack
Contact Dr. Novack